Nicole A Thomas1, Anna Drewry2, Susan Racine Passmore3, Nadia Assad4, Kara K Hoppe2. 1. University of Wisconsin-Madison, School of Nursing, Signe Skott Cooper Hall, 701 Highland Avenue, Madison, WI, 53705, USA. nathomas3@wisc.edu. 2. Department of Obstetrics and Gynecology, School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA. 3. University of Wisconsin-Madison, Collaborative Center for Health Equity, School of Medicine and Public Health, Madison, WI, USA. 4. University of Wisconsin-Madison Survey Center, Madison, WI, USA.
Abstract
BACKGROUND: Our aim was to conduct a post participation survey of respondent experiences with in-home remote patient monitoring via telehealth for blood pressure monitoring of women with postpartum hypertension. We hypothesized that the in-home remote patient monitoring application will be implemented with strong fidelity and have positive patient acceptability. METHODS: This analysis was a planned secondary analysis of a non-randomized controlled trial of telehealth with remote blood pressure patient monitoring for postpartum hypertension compared to standard outpatient monitoring in women with a hypertension-related diagnosis during pregnancy. In collaboration with survey experts, we developed a 41-item web-based survey to assess 1) perception of quality of care received, 2) ease of use/ease to learn the telehealth program, 3) effective orientation of equipment, 4) level of perceived security/privacy utilizing telehealth and 5) problems encountered. The survey included multiple question formats including Likert scale responses, dichotomous Yes/No responses, and free text. We performed a descriptive analysis on all responses and then performed regression analysis on a subset of questions most relevant to the domains of interest. The qualitative data collected through open ended responses was analyzed to determine relevant categories. Intervention participants who completed the study received the survey at the 6-week study endpoint. RESULTS: Sixty six percent of respondents completed the survey. The majority of women found the technology fit easily into their lifestyle. Privacy concerns were minimal and factors that influenced this included age, BMI, marital status, and readmissions. 95% of women preferred remote care for postpartum follow-up, in which hypertensive type, medication use and ethnicity were found to be significant factors in influencing location of follow-up. Most women were satisfied with the devices, but rates varied by hypertensive type, infant discharge rates and BMI. CONCLUSIONS: Postpartum women perceived the telehealth remote intervention was a safe, easy to use method that represented an acceptable burden of care and an overall satisfying method for postpartum blood pressure monitoring. TRIAL REGISTRATION: ClinicalTrials.gov identification number: NCT03111095 Date of registration: April 12, 2017.
BACKGROUND: Our aim was to conduct a post participation survey of respondent experiences with in-home remote patient monitoring via telehealth for blood pressure monitoring of women with postpartum hypertension. We hypothesized that the in-home remote patient monitoring application will be implemented with strong fidelity and have positive patient acceptability. METHODS: This analysis was a planned secondary analysis of a non-randomized controlled trial of telehealth with remote blood pressure patient monitoring for postpartum hypertension compared to standard outpatient monitoring in women with a hypertension-related diagnosis during pregnancy. In collaboration with survey experts, we developed a 41-item web-based survey to assess 1) perception of quality of care received, 2) ease of use/ease to learn the telehealth program, 3) effective orientation of equipment, 4) level of perceived security/privacy utilizing telehealth and 5) problems encountered. The survey included multiple question formats including Likert scale responses, dichotomous Yes/No responses, and free text. We performed a descriptive analysis on all responses and then performed regression analysis on a subset of questions most relevant to the domains of interest. The qualitative data collected through open ended responses was analyzed to determine relevant categories. Intervention participants who completed the study received the survey at the 6-week study endpoint. RESULTS: Sixty six percent of respondents completed the survey. The majority of women found the technology fit easily into their lifestyle. Privacy concerns were minimal and factors that influenced this included age, BMI, marital status, and readmissions. 95% of women preferred remote care for postpartum follow-up, in which hypertensive type, medication use and ethnicity were found to be significant factors in influencing location of follow-up. Most women were satisfied with the devices, but rates varied by hypertensive type, infant discharge rates and BMI. CONCLUSIONS: Postpartum women perceived the telehealth remote intervention was a safe, easy to use method that represented an acceptable burden of care and an overall satisfying method for postpartum blood pressure monitoring. TRIAL REGISTRATION: ClinicalTrials.gov identification number: NCT03111095 Date of registration: April 12, 2017.
Authors: Sarah J Rhoads; Christina I Serrano; Christian E Lynch; Songthip T Ounpraseuth; C Heath Gauss; Nalin Payakachat; Curtis L Lowery; Hari Eswaran Journal: Telemed J E Health Date: 2017-05-05 Impact factor: 3.536
Authors: Kara K Hoppe; Makeba Williams; Nicole Thomas; Julia B Zella; Anna Drewry; KyungMann Kim; Thomas Havighurst; Heather M Johnson Journal: Pregnancy Hypertens Date: 2018-12-31 Impact factor: 2.899
Authors: Alisse Hauspurg; Lara S Lemon; Beth A Quinn; Anna Binstock; Jacob Larkin; Richard H Beigi; Andrew R Watson; Hyagriv N Simhan Journal: Obstet Gynecol Date: 2019-10 Impact factor: 7.661
Authors: Lisa Hinton; Katherine L Tucker; Sheila M Greenfield; James A Hodgkinson; Lucy Mackillop; Christine McCourt; Trisha Carver; Carole Crawford; Margaret Glogowska; Louise Locock; Mary Selwood; Kathryn S Taylor; Richard J McManus Journal: BMC Pregnancy Childbirth Date: 2017-12-19 Impact factor: 3.007
Authors: Robin Chatters; Cindy L Cooper; Alicia O'Cathain; Caroline Murphy; Athene Lane; Katie Sutherland; Christopher Burton; Angela Cape; Louis Tunnicliffe Journal: BMC Med Res Methodol Date: 2022-04-29 Impact factor: 4.612